Justin L. Grodin

Parkland Health & Hospital System — United States

Medicine · Health Sciences

37h-index4.9kcitations302works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heart Failure Treatment and Management(103), Cardiovascular Function and Risk Factors(65), Amyloidosis: Diagnosis, Treatment, Outcomes(53), Parathyroid Disorders and Treatments(29), Mechanical Circulatory Support Devices(29)

Publications302 total

Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy
JACC Heart Failure·2025Open Access
Associations of Electromechanical Activation Time With Cardiac Structure and Function and Clinical Outcomes
JACC Advances·2025Open Access
Abstract 4368295: Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results From the ATTRibute-CM Study
Circulation·2025
Abstract 4362348: A Case of Concomitant Wild-Type Transthyretin and Systemic Light Chain Amyloidosis Involving Separate Organs
Circulation·2025
Abstract 4368185: Serum Transthyretin Levels at Day 28 are Associated with Cardiovascular Outcomes: Insights From the ATTRibute-CM Study
Circulation·2025
Twin Diseases in Different Organs: A Cautionary Tale of Anchoring on a Positive Scan
Circulation·2025
Abstract 4364102: Acoramidis Reduces All-Cause Mortality and Cardiovascular-Related Hospitalizations Through Month 42 in Transthyretin Amyloid Cardiomyopathy Across All Pre-specified Patient Subgroups
Circulation·2025
Association of blood biomarkers with cardiovascular and kidney adverse outcomes in people with heart failure with preserved ejection fraction
European Heart Journal·2025Open Access
Transthyretin Amyloid Cardiomyopathy: The Plot Thickens as Novel Therapies Emerge
US Cardiology Review·2025Open Access
Novel 4-Stage Classification to Estimate Right Atrial Pressure by Point-of-Care Ultrasound of Neck Vasculature
JACC Heart Failure·2025Open Access
Clinical Implications of the P.V142I TTR Variant
JACC Heart Failure·2025
A Rare Unusually Aggressive Form of Hereditary Transthyretin Amyloidosis
JACC Case Reports·2025Open Access
Biomarkers Associated with Albuminuria in Heart Failure with Preserved Ejection Fraction (HFpEF)
Journal of the American Society of Nephrology·2025
Epic Cosmos to Describe AKI Events in Acute Heart Failure
Journal of the American Society of Nephrology·2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM
Journal of the American College of Cardiology·2025· 3 citedOpen Access
Forging a New Path: Evolving Training Experiences and Challenges in Cardiac Amyloidosis Fellowships
Journal of Cardiac Failure - Intersections·2025Open Access
Acoramidis Improves Serum Transthyretin Levels in Patients With Wild-type or Variant Transthyretin Amyloid Cardiomyopathy - Results From ATTRibute-CM
Journal of Nuclear Cardiology·2025
Single Ascending-Dose Study of Selective ErbB4 Agonist JK07 in Heart Failure With Reduced Ejection Fraction
JACC Basic to Translational Science·2025· 2 citedOpen Access
Management Patterns and Outcomes of Invasive Mechanical Ventilation in Patients With Cardiogenic Shock
JACC Advances·2025· 2 citedOpen Access
Risk for Heart Failure and Atrial Fibrillation Across the Lifespan for Carriers of the Amyloidogenic p.V142I <i>TTR</i> Variant
Circulation Genomic and Precision Medicine·2025· 4 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

W.H. Wilson Tang(27), Mark H. Drazner(12), Ambarish Pandey(12), Randall C. Starling(9), Javed Butler(7), Yuping Wu(7), Matthew W. Segar(6), Jarett D. Berry(6), Adrian F. Hernandez(6), G. Michael Felker(6), James A. de Lemos(5), Kershaw V. Patel(5), Wilfried Müllens(5), Susanna R. Stevens(5), Nicholas Hendren(4), Colby Ayers(4), Robert J. Mentz(4), Marco Metra(4), Adriaan A. Voors(4), John J.V. McMurray(4)